Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer.

L C Hartmann, C L Loprinzi

    Cancer Chemotherapy and Biological Response Modifiers
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    This review discusses key breast cancer advancements, including screening mammography for women 40-49 and optimizing adjuvant therapies for various patient groups. It also covers managing in situ carcinoma and improving anthracycline treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    The past and future of 'reported outcomes' in studies on chemotherapy neuropathy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Cancer-Associated Anorexia and Cachexia : Implications for Drug Therapy.

    Drugs·2017
    Same author

    Statistical controversies in clinical research: Value of adverse events relatedness to study treatment: analyses of data from randomized double-blind placebo-controlled clinical trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
    Same author

    Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same journal

    Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    DNA vaccines for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Chemotherapy, cytokines, and biochemotherapy for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Current status of interferon-alpha in the treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    See all related articles

    Area of Science:

    • Oncology
    • Breast Cancer Research
    • Clinical Practice Guidelines

    Background:

    • Breast cancer management involves continuous evaluation of screening protocols and treatment strategies.
    • Recent advancements necessitate a review of established practices and emerging evidence.

    Purpose of the Study:

    • To summarize and discuss pivotal debates and advancements in breast cancer care over the past year.
    • To highlight key areas for clinical consideration and future research.

    Main Methods:

    • Review of recent scientific literature and clinical trial data.
    • Synthesis of expert opinions and consensus statements on breast cancer management.

    Main Results:

    • Debates include the efficacy of screening mammography in women aged 40-49.

    Related Experiment Videos

  • Management strategies for carcinoma in situ and adjuvant therapies for node-positive and node-negative postmenopausal women were discussed.
  • Primary management approaches for elderly breast cancer patients were examined.
  • The utility of composite prognostic factors and methods to enhance the therapeutic index of anthracyclines were evaluated.

    • Conclusions:

    • Ongoing research and clinical debate are crucial for refining breast cancer screening and treatment.
    • Personalized medicine approaches, utilizing prognostic factors, are essential for optimizing patient outcomes.
    • Improving the safety and efficacy of existing therapies, like anthracyclines, remains a priority.